Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
197
datasets available to search
ShareScore release 0.7.1
Dataset results
197 results for “BCMA”
A Phase 1/2 Study of a Fully Human BCMA-targeting CAR (CT103A) in Patients With Relapsed/Refractory Multiple Myeloma (FUMANBA-1)
ClinicalTrials.gov study NCT05066646. IPD Sharing: NO. Countries: 1. Publications: 2.
BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma
ClinicalTrials.gov study NCT03502577. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
ClinicalTrials.gov study NCT03815383. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of ALLO-715 BCMA Allogenic CAR T Cells in in Adults With Relapsed or Refractory Multiple Myeloma (UNIVERSAL)
ClinicalTrials.gov study NCT04093596. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
ClinicalTrials.gov study NCT06066346. IPD Sharing: YES. Countries: 1. Publications: 0.
Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies
ClinicalTrials.gov study NCT05191472. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Trial of BCMA-TGF-BETA CAR-T Cells in Relapsed, Refractory Myeloma
ClinicalTrials.gov study NCT05976555. IPD Sharing: NO. Countries: 0. Publications: 1.
A Safety Study of SEA-BCMA in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT03582033. IPD Sharing: Not stated. Countries: 1. Publications: 0.
UF-KURE-BCMA CAR-T Cells in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06698744. IPD Sharing: YES. Countries: 1. Publications: 0.
DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM
ClinicalTrials.gov study NCT07377435. IPD Sharing: YES. Countries: 1. Publications: 0.
Single-cell transcriptomic sequencing of BCMA CAR-T cells during CAR-T therapy in refractory primary plasma cell leukemia
GEO Series GSE151310. Homo sapiens. 20 samples. Type: Expression profiling by high throughput sequencing.
Hypoxia promotes BCMA loss and a suppressive secretome thereby hindering CAR T cell therapy in multiple myeloma
GEO Series GSE307311. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.
CD4+ CAR-T cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR-T cell therapy
GEO Series GSE274187. Homo sapiens. 23 samples. Type: Expression profiling by high throughput sequencing; Other.
Single cell multi-omic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma
GEO Series GSE234261. Homo sapiens. 100 samples. Type: Expression profiling by high throughput sequencing; Other.
CD4+ CAR-T cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR-T cell therapy I
GEO Series GSE246342. Homo sapiens. 18 samples. Type: Expression profiling by high throughput sequencing; Other.
Genetic Disruption of Blimp-1 Drastically Augments the Anti-Tumour Efficacy of BCMA-Targeting CAR-T Cells
GEO Series GSE255977. Homo sapiens. 8 samples. Type: Expression profiling by high throughput sequencing.
CAR Density Influences Antitumoral Efficacy of BCMA CAR T Cells and Correlates with Clinical Outcome
GEO Series GSE197851. Homo sapiens. 54 samples. Type: Expression profiling by high throughput sequencing; Genome binding/occupancy profiling by high throughput sequencing.
Halting Multiple Myeloma with MALT1 Inhibition: Suppressing BCMA-Induced NF-κB and Inducing Immunogenic Cell Death
GEO Series GSE266548. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
High-specificity CRISPR-mediated genome engineering in CB-011, an anti-BCMA allogeneic CAR-T cell, suppresses allograft rejection in preclinical models
GEO Series GSE249316. Homo sapiens. 18 samples. Type: Expression profiling by high throughput sequencing.
Immune correlates of anti-BCMA CAR-T products idecabtagene vicleucel and ciltacabtagene autoleucel in a real-world cohort of patients with multiple myeloma [scRNA-seq]
GEO Series GSE298012. Homo sapiens. 2 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.